Summary & Overview
CPT 46500: Injection Sclerotherapy for Hemorrhoid
CPT code 46500 covers sclerotherapy for internal hemorrhoids, specifically injection of a sclerosing solution into the submucosa beneath a hemorrhoid to reduce blood flow and induce shrinkage. This minimally invasive procedural code is commonly used in ambulatory and office-based settings and is a frequent alternative to more invasive hemorrhoid treatments for appropriate candidates. Nationally, the code is relevant for outpatient surgical workflows, prior authorization pathways, and payer coverage policies that differentiate between conservative, office-based procedures and facility-based interventions.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for sclerotherapy, benchmarks for typical sites of service, and how payers commonly categorize this service for coverage and billing. The publication outlines coding considerations, common modifiers reported with procedural services (input provided), and areas where documentation supports medical necessity.
The report is intended for billing professionals, clinicians who perform hemorrhoid procedures, and policy analysts seeking clarity on mapping procedure use across payer policies. It summarizes the clinical purpose of the procedure, where it is typically performed, and the payer landscape relevant to CPT code 46500. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 46500 describes injection of a sclerosing solution into the submucosa beneath a hemorrhoid in the lower anal canal. This procedure is intended to reduce blood flow to the hemorrhoidal tissue and promote shrinkage of the hemorrhoid.
-
Service type: Office or outpatient procedural treatment for internal hemorrhoids involving sclerotherapy
-
Typical site of service: Ambulatory surgery center, outpatient clinic, or office procedure room
Clinical & Coding Specifications
Clinical Context
A 48-year-old outpatient presents to a colorectal clinic with symptomatic internal hemorrhoids causing intermittent bleeding, prolapse with manual reduction, and localized discomfort. After history and focused anorectal examination, the clinician recommends office-based sclerotherapy. The procedure is performed with the patient in the left lateral decubitus position, using anoscopic visualization. A sclerosing solution is injected into the submucosa at the base of the internal hemorrhoid to induce fibrosis and shrinkage. Vital signs and anticoagulation status are reviewed pre-procedure, informed consent is obtained, and topical or local anesthetic is applied as indicated. The patient is monitored briefly post-procedure, provided post-care instructions for pain control and bowel regimen, and scheduled for follow-up to assess symptom relief and need for additional sessions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is documented on the same day as 46500 (e.g., new symptoms requiring evaluation before sclerotherapy). |
52 |